Historical record - last NADAC effective date: 11/18/2020

Product Information

QC ACETAMINOPHEN 8-HR 650 MG is a generic product labeled by Chain Drug Marketing Association, priced at $0.0606 per EA under NDC 63868009150. Its NADAC has been published 193 times since Mar 29, 2017.

FDA first approved this application on Mar 19, 2002.

QC ACETAMINOPHEN 8-HR 650 MG

Acetaminophen
$0.0606per EA
OTC

Strength

650 mg/1

NDC

63868009150

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2020

Active Ingredients

ACETAMINOPHEN

Approval Type

Generic (ANDA)

FDA Application

ANDA076200

FDA Approved

3/19/2002

On Market Since

4/30/2002

Price Statistics

The NADAC for QC ACETAMINOPHEN 8-HR 650 MG has been published 193 times since Mar 29, 2017, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0606 per EA
All-time high$0.0683 (Nov 13, 2019)
All-time low$0.0572 (Oct 17, 2018)
Median price$0.0618
Average price$0.0616
Largest weekly change+12.1% (Oct 23, 2019)
Weeks tracked193
Tracking sinceMar 29, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-3.1%

Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of QC ACETAMINOPHEN 8-HR 650 MG?

The current National Average Drug Acquisition Cost (NADAC) for QC ACETAMINOPHEN 8-HR 650 MG, manufactured by Chain Drug Marketing Association, is $0.0606 per EA (NDC 63868009150), effective Dec 2, 2020.

How has the price of QC ACETAMINOPHEN 8-HR 650 MG changed over time?

Over the history we have for it, the NADAC for QC ACETAMINOPHEN 8-HR 650 MG has declined 3.1%. It has been tracked across 193 weekly CMS publications since Mar 29, 2017.

What are the highest and lowest recorded NADAC prices for QC ACETAMINOPHEN 8-HR 650 MG?

Since Mar 29, 2017, the NADAC for QC ACETAMINOPHEN 8-HR 650 MG has ranged from a low of $0.0572 (Oct 17, 2018) to a high of $0.0683 (Nov 13, 2019), with a median of $0.0618 per EA.

Are there cheaper alternatives to QC ACETAMINOPHEN 8-HR 650 MG?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARTHRITIS PAIN ER 650 MG CAPLT, is $0.0599 per EA — about 1% below QC ACETAMINOPHEN 8-HR 650 MG.

Who manufactures QC ACETAMINOPHEN 8-HR 650 MG?

QC ACETAMINOPHEN 8-HR 650 MG (NDC 63868009150) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.